Literature DB >> 19197590

Substance abuse treatment clinician opinions and infectious disease service delivery.

Kathlene Tracy1, Lawrence S Brown, Steven Kritz, Donald Alderson, Jim Robinson, Edmund J Bini, Michael Levy, Donald Calsyn, Traci Rieckmann, Bret Fuller, Pat McAuliffe, John Rotrosen.   

Abstract

Substance abuse treatment programs are an important platform for delivery of services for infectious diseases associated with drug and alcohol use. However, important components of infectious disease care are not universally provided. Clinician training often focuses on information about infectious diseases and less attention is paid to provider opinions and attitudes that may be barriers to providing infectious diseases services. In a national multi-site trial conducted by the National Drug Abuse Treatment Clinical Trials Network (CTN), we investigated the relationship between clinician opinions and the delivery of services for human immunodeficiency virus, hepatitis C virus, and sexually transmitted infections in substance abuse treatment settings. Survey data were collected from 1,723 clinicians at 269 CTN treatment programs. Clinician opinion was found to be significantly related to infectious disease service delivery. Implications for training are discussed.

Entities:  

Mesh:

Year:  2009        PMID: 19197590      PMCID: PMC3102438          DOI: 10.1080/10550880802544625

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  6 in total

1.  Gaps in the drug-free and methadone treatment program response to Hepatitis C.

Authors:  Shiela M Strauss; Janetta Astone; Zdravko P Vassilev; Don C Des Jarlais; Holly Hagan
Journal:  J Subst Abuse Treat       Date:  2003-06

2.  Co-located substance use treatment and HIV prevention and primary care services, New York State, 1990-2002: a model for effective service delivery to a high-risk population.

Authors:  Jeffrey Rothman; Diane Rudnick; Marc Slifer; Bruce Agins; Karl Heiner; Guthrie Birkhead
Journal:  J Urban Health       Date:  2007-03       Impact factor: 3.671

3.  Addressing the need for HIV specialists: the AAHIVM perspective.

Authors:  Howard A Grossman
Journal:  AIDS Read       Date:  2006-09

Review 4.  Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users.

Authors:  Brian R Edlin; Thomas F Kresina; Daniel B Raymond; Michael R Carden; Marc N Gourevitch; Josiah D Rich; Laura W Cheever; Victoria A Cargill
Journal:  Clin Infect Dis       Date:  2005-04-15       Impact factor: 9.079

5.  A nationwide survey of hepatitis C services provided by drug treatment programs.

Authors:  Shiela M Strauss; Gregory P Falkin; Zdravko Vassilev; Don C Des Jarlais; Janetta Astone
Journal:  J Subst Abuse Treat       Date:  2002-03

6.  Injection drug users and the provision of hepatitis C-related services in a nationwide sample of drug treatment programs.

Authors:  Zdravko P Vassilev; Shiela M Strauss; Janetta Astone; Don C Des Jarlais
Journal:  J Behav Health Serv Res       Date:  2004 Apr-Jun       Impact factor: 1.505

  6 in total
  6 in total

1.  Assessment of methadone clinic staff attitudes toward hepatitis C evaluation and treatment.

Authors:  Andrew H Talal; Rositsa B Dimova; Randy Seewald; Raymond H Peterson; Marija Zeremski; David C Perlman; Don C Des Jarlais
Journal:  J Subst Abuse Treat       Date:  2012-03-08

2.  Adoption and utilization of sexually transmitted infections testing in outpatient substance abuse treatment facilities serving high risk populations in the U.S.

Authors:  Erick G Guerrero; Julie A Cederbaum
Journal:  Int J Drug Policy       Date:  2010-10-20

3.  Human immunodeficiency virus testing practices among buprenorphine-prescribing physicians.

Authors:  E Jennifer Edelman; An T Dinh; Brent A Moore; Richard S Schottenfeld; David A Fiellin; Lynn E Sullivan
Journal:  J Addict Med       Date:  2012-06       Impact factor: 3.702

4.  Community Providers' Impression of HIV Prevention Intervention Research in NIDA's Clinical Trials Network.

Authors:  Aimee N C Campbell; Bryan Hartzler; Mary Hatch-Maillette; Donald A Calsyn; Gloria M Miele; Susan Tross
Journal:  J Drug Issues       Date:  2011

5.  Challenges to implementing opioid substitution therapy in Ukrainian prisons: Personnel attitudes toward addiction, treatment, and people with HIV/AIDS.

Authors:  Maxim Polonsky; Lyuba Azbel; Jeffrey A Wickersham; Faye S Taxman; Evgeny Grishaev; Sergey Dvoryak; Frederick L Altice
Journal:  Drug Alcohol Depend       Date:  2014-12-22       Impact factor: 4.492

6.  The Future of Opioid Agonist Therapies in Ukraine: A Qualitative Assessment of Multilevel Barriers and Ways Forward to Promote Retention in Treatment.

Authors:  Martha J Bojko; Alyona Mazhnaya; Ruthanne Marcus; Iuliia Makarenko; Zahedul Islam; Sergey Filippovych; Sergii Dvoriak; Frederick L Altice
Journal:  J Subst Abuse Treat       Date:  2016-03-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.